English

CTT PHARMACEUTICAL HOLDINGS, INC.

EDGAR

CTTH Current report (8-K) · filed 2026-10-30

92 filing records in this dataset, filed from 2000-08-24 to 2026-10-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 32.1 thousand USD 2015-09-30 Source
Exact value

32121 USD
Long-term debt including current maturities: Not available
Shares outstanding: 21.3 million shares 2015-09-30 Source
Exact value

21319302 shares

Reported share-count change

-88.44% · -163 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

184368022 shares · 2014-09-30· Source
21319302 shares · 2015-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2014-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2006-12-31
Operating income: 11 of 11 periods available· newest 2014-12-31
Net income: 11 of 11 periods available· newest 2014-12-31
Operating cash flow: 9 of 11 periods available· newest 2014-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2014-12-31
Total liabilities: 9 of 11 periods available· newest 2014-12-31
Current assets: 11 of 11 periods available· newest 2014-12-31
Current liabilities: 10 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2014-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 653,251

Prior period

−USD 18,911

2013-01-01 – 2013-12-31
Current period

−USD 672,162

2014-01-01 – 2014-12-31

Exact inputs and evidence

-672162 − -18911 = -653251 USD

-18911 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-672162 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2014-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Year-over-year change in Net income: -653251 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -672162 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001276/mdst-20150930.xml#39535 Filing: 000155335015001276 Input fundies:NetIncome: -18911 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001276/mdst-20150930.xml#38972 Filing: 000155335015001276
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 72,041

Prior period

−USD 209

2013-01-01 – 2013-12-31
Current period

−USD 72,250

2014-01-01 – 2014-12-31

Exact inputs and evidence

-72250 − -209 = -72041 USD

-209 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-72250 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2014-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Year-over-year change in Operating cash flow: -72041 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -72250 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001055/mdst-20141231.xml#61989 Filing: 000155335015001055 Input fundies:OperatingCashFlow: -209 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001055/mdst-20141231.xml#62172 Filing: 000155335015001055
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2006-01-01 – 2006-12-31

Revenue USD 3,040 100% of revenue
Operating costs Derived USD 1.26 million 41,402% of revenue
Operating income −USD 1.26 million −41,302% of revenue
Tax, interest and other Derived USD 0 0% of revenue
Net income −USD 1.26 million −41,302% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Operating loss: operating costs were 242,760% of revenue.
2006 Operating loss: operating costs were 41,402% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	760	1844979 Derived	-1844219	0 Derived	-1844219	Unavailable	Source 2005-01-01 – 2005-12-31: 760 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -1844219 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -1844219 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -1526059 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	3040	1258624 Derived	-1255584	0 Derived	-1255584	Unavailable	Source 2006-01-01 – 2006-12-31: 3040 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -1255584 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -1255584 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3K 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	760	Revenue: 760 Open source
20062006-12-31	Revenue	3040	Revenue: 3040 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

300% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 760 Open source Revenue: 0 Open source
20062006-12-31	Year over year	300%	Revenue: 3040 Open source Revenue: 760 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -41,302.1% 2006

Net margin -41,302.1% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	Not reported	Operating Income: -1608884 Open source Revenue: 0 Open source
20052005-12-31	Operating margin	-242,660.4%	Operating Income: -1844219 Open source Revenue: 760 Open source
20062006-12-31	Operating margin	-41,302.1%	Operating Income: -1255584 Open source Revenue: 3040 Open source
20042004-12-31	Net margin	Not reported	Net Income: -561153 Open source Revenue: 0 Open source
20052005-12-31	Net margin	-242,660.4%	Net Income: -1844219 Open source Revenue: 760 Open source
20062006-12-31	Net margin	-41,302.1%	Net Income: -1255584 Open source Revenue: 3040 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 760 Open source Operating Cash Flow: -1526059 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 3040 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.5M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	-1526059	Operating Cash Flow: -1526059 Open source
20062006-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	No source recorded
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1526059 Open source
20062006-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.7% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Liabilities / assets	11.6%	Total Liabilities: 251015 Open source Total Assets: 2169442 Open source
20052005-12-31	Liabilities / assets	96.6%	Total Liabilities: 2083943 Open source Total Assets: 2158151 Open source
20062006-12-31	Liabilities / assets	55.7%	Total Liabilities: 962582 Open source Total Assets: 1727609 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	0.68×	Current Assets: 160980 Open source Current Liabilities: 238383 Open source
20052005-12-31	Current assets / current liabilities	0.61×	Current Assets: 157974 Open source Current Liabilities: 257012 Open source
20062006-12-31	Current assets / current liabilities	0.05×	Current Assets: 16759 Open source Current Liabilities: 349805 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 1.84 million Exact value Exact value: -1844219 USD 2005-01-01 – 2005-12-31: -1844219 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2005-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1844219 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1844219 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001079973-07-000201.txt#1527 The citation records this snapshot. The page link may show a newer release later.	−USD 1.53 million Exact value Exact value: -1526059 USD 2005-01-01 – 2005-12-31: -1526059 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2005-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -1526059 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1526059 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001065949-06-000041.txt#1759 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 1.26 million Exact value Exact value: -1255584 USD 2006-01-01 – 2006-12-31: -1255584 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2006-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1255584 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1255584 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001079973-08-000353.txt#1497 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 2.76 million Exact value Exact value: -2761456 USD 2007-01-01 – 2007-12-31: -2761456 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2007-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -2761456 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2761456 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001079973-09-000339.txt#1826 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 1.58 million Exact value Exact value: -1579801 USD 2008-01-01 – 2008-12-31: -1579801 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2008-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1579801 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1579801 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001144204-10-025548.txt#4542 The citation records this snapshot. The page link may show a newer release later.	−USD 605,934 Exact value Exact value: -605934 USD 2008-01-01 – 2008-12-31: -605934 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2008-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -605934 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -605934 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001144204-10-025548.txt#4804 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 1.63 million Exact value Exact value: -1629281 USD 2009-01-01 – 2009-12-31: -1629281 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2009-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1629281 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1629281 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0000912282-11-000169.txt#4399 The citation records this snapshot. The page link may show a newer release later.	−USD 513,285 Exact value Exact value: -513285 USD 2009-01-01 – 2009-12-31: -513285 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2009-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -513285 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -513285 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/0001144204-10-025548.txt#4804 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 1.1 million Exact value Exact value: -1097719 USD 2010-01-01 – 2010-12-31: -1097719 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2010-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1097719 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1097719 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000120445912000549/idsm-20111231.xml#69889 Filing: 000120445912000549 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1674602 USD 2010-01-01 – 2010-12-31: -1674602 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2010-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -1674602 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1674602 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000120445912000549/idsm-20111231.xml#73792 Filing: 000120445912000549 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	USD 3.74 million Exact value Exact value: 3738515 USD 2011-01-01 – 2011-12-31: 3738515 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2011-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: 3738515 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3738515 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000106299313001090/idsm-20121231.xml#67316 Filing: 000106299313001090 The citation records this snapshot. The page link may show a newer release later.	−USD 316,132 Exact value Exact value: -316132 USD 2011-01-01 – 2011-12-31: -316132 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2011-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -316132 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -316132 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000106299313001090/idsm-20121231.xml#72838 Filing: 000106299313001090 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 1 million Exact value Exact value: -1003188 USD 2012-01-01 – 2012-12-31: -1003188 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2012-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -1003188 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1003188 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000106299314000591/idsm-20131231.xml#68577 Filing: 000106299314000591 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Exact value Exact value: -1027011 USD 2012-01-01 – 2012-12-31: -1027011 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2012-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -1027011 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1027011 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000106299314000591/idsm-20131231.xml#74503 Filing: 000106299314000591 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 18,911 Exact value Exact value: -18911 USD 2013-01-01 – 2013-12-31: -18911 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2013-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -18911 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18911 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001276/mdst-20150930.xml#38972 Filing: 000155335015001276 The citation records this snapshot. The page link may show a newer release later.	−USD 209 Exact value Exact value: -209 USD 2013-01-01 – 2013-12-31: -209 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2013-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -209 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -209 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001055/mdst-20141231.xml#62172 Filing: 000155335015001055 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 672,162 Exact value Exact value: -672162 USD 2014-01-01 – 2014-12-31: -672162 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTT PHARMACEUTICAL HOLDINGS, INC. · 2014-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Net Income: -672162 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -672162 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001276/mdst-20150930.xml#39535 Filing: 000155335015001276 The citation records this snapshot. The page link may show a newer release later.	−USD 72,250 Exact value Exact value: -72250 USD 2014-01-01 – 2014-12-31: -72250 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTT PHARMACEUTICAL HOLDINGS, INC. · 2014-12-31 CTT PHARMACEUTICAL HOLDINGS, INC. (edgar:1035422) Operating Cash Flow: -72250 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:05:43Z Snapshot: 56423c48ac83b54528f8cb569036bbb1e0e4607766e1634210f48d41ca4736a5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1035422/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72250 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1035422/000155335015001055/mdst-20141231.xml#61989 Filing: 000155335015001055 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

92 filings · 1,000 latest values · 1,002 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001035422, 1035422, CTTH, edgar:1035422, idsm, mdst

Also known as CTT PHARMACEUTICAL HOLDINGS, INC., CTT Pharmaceutical Holdings, Inc., INDUSTRIAL MINERALS INC, Mindesta Inc., PNW CAPITAL INC, WINCHESTER MINING CORP

CTT PHARMACEUTICAL HOLDINGS, INC.

Latest quarter

Revenue

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2006 2006-01-01 – 2006-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation